Annual report
8938.TEDINET S100YJMT
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 143
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.0bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥1.2bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | −¥37m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥46m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | −¥358m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥53m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥192m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥268m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥346m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥530m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥98m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥538m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥70m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥198m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥348m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥208m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥538m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥70m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥7.9bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥8.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥8.4bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.4bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.9bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥622m | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥806m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.3bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.8bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.8bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥7.7bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.5bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.8bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥236m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥260m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥187m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥755m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥196m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥627m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥366m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥38m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥769m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥172m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥30m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥43m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥45m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥364m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥276m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-59.55 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.82 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.91 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.47 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.09 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥23.08 | 2021-04-01 → 2022-03-31v | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥787.81 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥849.37 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥840.79 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥867.29 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥835.41 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 90.3% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.0% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.0% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 0.9% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 73 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 99 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 72 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 61 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 62 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥513m | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥499m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥496m | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥150m | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥222m | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | −¥3m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥3m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥26m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥31m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥24m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥357m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥380m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥291m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥188m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥296m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥149m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥45m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥192m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥125m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.2bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥7.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥7.4bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.4bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.9bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥250m | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥302m | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.2bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥7.2bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.3bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-32.77 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.48 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.02 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.23 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.85 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.02 | 2023-04-01 → 2024-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥2 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥755.63 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥790.4 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥773.91 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥773.9 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥801.13 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 94.5% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.2% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.4% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.9% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.0% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,051,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,051,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 17 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 19 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 16 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 16 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 15 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 47
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥406m |
| Company Widereportable segment | employees | at 2026-03-31 | 16 pure |
| Hospital Businessreportable segment | employees | at 2026-03-31 | 57 pure |
| Hospital Related Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥15m |
| Hospital Related Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.9bn |
| Hospital Related Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.9bn |
| Hospital Related Businessreportable segment | segment assets | at 2026-03-31 | ¥6.5bn |
| Hospital Related Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥319m |
| Real Estate Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥61m |
| Real Estate Businessreportable segment | employees | at 2026-03-31 | 0 pure |
| Real Estate Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥134m |
| Real Estate Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥134m |
| Real Estate Businessreportable segment | segment assets | at 2026-03-31 | ¥1.3bn |
| Real Estate Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥49m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥76m |
| —segment total | employees | at 2026-03-31 | 73 pure |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| —segment total | segment assets | at 2026-03-31 | ¥7.9bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥369m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥76m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥7.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥369m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥388m |
| Hospital Related Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥12m |
| Hospital Related Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Hospital Related Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Hospital Related Businessreportable segment | segment assets | at 2025-03-31 | ¥7.3bn |
| Hospital Related Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥285m |
| Real Estate Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥61m |
| Real Estate Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥139m |
| Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥139m |
| Real Estate Businessreportable segment | segment assets | at 2025-03-31 | ¥1.3bn |
| Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥56m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥74m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| —segment total | segment assets | at 2025-03-31 | ¥8.6bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥342m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥74m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥342m |
| Hospital Businessreportable segment | employees | at 2026-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,382
| Item | Context | Value | Unit |
|---|---|---|---|
| Total changes of items during the period | CurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember | -0 | JPY |
| Total changes of items during the period | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | -0 | JPY |
| Total changes of items during the period | CurrentYearDuration_SubscriptionRightsToSharesMember | -8000000 | JPY |
| Total changes of items during the period | CurrentYearDuration | -565000000 | JPY |
| Net assets | CurrentYearInstant_ForeignCurrencyTranslationAdjustmentMember | － | JPY |
| Net assets | CurrentYearInstant_ValuationAndTranslationAdjustmentsMember | － | JPY |
| Net assets | CurrentYearInstant_SubscriptionRightsToSharesMember | 143000000 | JPY |
| Net assets | CurrentYearInstant | 7273000000 | JPY |
| Income before income taxes | Prior1YearDuration | 98000000 | JPY |
| Income before income taxes | CurrentYearDuration | -530000000 | JPY |
| Depreciation and amortization ope cf | Prior1YearDuration | 74000000 | JPY |
| Depreciation and amortization ope cf | CurrentYearDuration | 76000000 | JPY |
| Amortization of goodwill ope cf | Prior1YearDuration | 17000000 | JPY |
| Amortization of goodwill ope cf | CurrentYearDuration | 17000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YearDuration | -5000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYearDuration | -39000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YearDuration | 15000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | -15000000 | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -2000000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -5000000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 0 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 0 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | 3000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | 313000000 | JPY |
| Loss on retirement of noncurrent assets ope cf | Prior1YearDuration | 0 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYearDuration | 1000000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YearDuration | -8000000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYearDuration | － | JPY |
| Impairment loss ope cf | Prior1YearDuration | － | JPY |
| Impairment loss ope cf | CurrentYearDuration | 71000000 | JPY |
| Loss on valuation of investments in capital ope cf | Prior1YearDuration | 5000000 | JPY |
| Loss on valuation of investments in capital ope cf | CurrentYearDuration | 7000000 | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | Prior1YearDuration | － | JPY |
| Loss gain on sales of stocks of subsidiaries and affiliates ope cf | CurrentYearDuration | 83000000 | JPY |
| Gain on reversal of subscription rights to shares ope cf | Prior1YearDuration | -7000000 | JPY |
| Gain on reversal of subscription rights to shares ope cf | CurrentYearDuration | -8000000 | JPY |
| Demolition cost ope cf | Prior1YearDuration | 9000000 | JPY |
| Demolition cost ope cf | CurrentYearDuration | － | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -52000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | 37000000 | JPY |
| Decrease increase in operating loans receivable ope cf | Prior1YearDuration | -503000000 | JPY |
| Decrease increase in operating loans receivable ope cf | CurrentYearDuration | -114000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | 0 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | 2000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 168000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | -143000000 | JPY |
| Decrease increase in advances paid ope cf | Prior1YearDuration | 0 | JPY |
| Decrease increase in advances paid ope cf | CurrentYearDuration | 0 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YearDuration | 18000000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYearDuration | 0 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |